Novel Eye Drop to Relieve Presbyopia Enters Phase 3 Clinicals
Sunday, November 8 2020 | 11 h 54 min | Latest News, Press Release, Vision Science
Orasis Pharmaceuticals, an Israeli based ophthalmic pharmaceutical company announced the start of Phase 3 clinical studies in the US to...
Read MoreSightRisk AMD Assessment Tool Makes North American Debut at VEW
Friday, September 4 2015 | 00 h 00 min | New Products, Press Release
SightRisk, a cloud-based AMD risk assessment tool, will launch to North America ECPs at Vision Expo West in Las Vegas on September 17, 2015 The...
Read More